Unconventional Pharmaceutical Drug-Templated In-Situ Electrochemical Synthesis of Redox-Active Fe-MOF/MWCNT Hybrids for Point-of-Care Voltammetric pH Sensing

Abstract

Metal-organic frameworks (MOFs), a class of porous hybrid materials formed by the coordination of organic linkers with transition-metal centres, have attracted considerable interest owing to their tunable physicochemical properties and wide-ranging applications in chemistry, electrochemistry, and biomedicine. In this study, we report for the first time the use of a non-steroidal anti-inflammatory drug (NSAID), etodolac (ETO), as an unconventional molecular template for the in situ electrochemical synthesis of Fe-MOFs on Fe impregnated multi-walled carbon nanotube (MWCNT) and other carbon-nanomaterial-modified electrodes in neutral phosphate buffer (pH 7). The resulting hybrid materials, denoted as MWCNT@Feint-MOF and MWCNT@Feext-MOF, correspond to intrinsic and extrinsic Fe species, respectively. Comprehensive characterisation using FE-SEM, FTIR, Raman spectroscopy, XRD, XPS, EQCM, and cyclic voltammetry confirmed that, under anodic polarization at +1.0 V (vs. Ag/AgCl), Fe³⁺ ions were electrochemically stripped from the electrode surface, while ETO was oxidized to a reactive dimeric intermediate, forming ETO-N-N-ETO linkages (dETO). These coupled processes promoted the growth of Fe-MOF architectures on the graphitic domains of carbon nanomaterials, yielding a unique hybrid organic-inorganic framework with excellent conductivity and Nernstian proton-coupled electron-transfer (PCET) redox behaviour. As a proof of concept, a disposable three-in-one screen-printed electrode (SPE) modified with MWCNT@Fe-MOF and integrated with a portable programmable potentiostat enabled a rapid one-drop pH sensing application. The system was successfully validated on various real samples. Overall, this work introduces pharmaceutical drugs as unconventional molecular templates for MOF synthesis, offering a novel strategy for the design of advanced electrochemical redox systems for device development and practical applications.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
20 Oct 2025
Accepted
13 Jan 2026
First published
16 Feb 2026

J. Mater. Chem. A, 2026, Accepted Manuscript

Unconventional Pharmaceutical Drug-Templated In-Situ Electrochemical Synthesis of Redox-Active Fe-MOF/MWCNT Hybrids for Point-of-Care Voltammetric pH Sensing

K. Vignesh, N. A. Ayyakannu and A. Senthil Kumar, J. Mater. Chem. A, 2026, Accepted Manuscript , DOI: 10.1039/D5TA08509H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements